Amie B Park1, Kathleen M Darcy2, Chunqiao Tian3, Yovanni Casablanca4, Jill K Schinkel1, Lindsey Enewold5, Katherine A McGlynn5, Craig D Shriver6, Kangmin Zhu7. 1. John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. 2. John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA. 3. Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA. 4. John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD, USA. 5. National Cancer Institute, Bethesda, MD, USA. 6. John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 7. John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. Electronic address: kzhu@murthacancercenter.org.
Abstract
OBJECTIVE: The mortality rate for Black women with endometrial cancer (EC) is double that of White women, although the incidence rate is lower among Black women. Unequal access to care may contribute to this racial disparity. This study aimed to assess whether survival varied between non-Hispanic Black (NHB) and non-Hispanic White (NHW) women with EC in the Military Health System (MHS) which provides equal access care to its beneficiaries despite racial/ethnic background. METHODS: The study was conducted using data from the U.S. Department of Defense's (DoD) Automated Central Tumor Registry (ACTUR). Study subjects included NHB and NHW women with histologically confirmed and surgically managed EC diagnosed between 1988 and 2013. The study outcome was all-cause death. Overall survival between NHB and NHW women was compared using multivariable Cox modeling. RESULTS: The study included 144 NHB and 1439 NHW women with EC. Kaplan-Meier curves showed NHB women had worse survival than NHW women (log-rank P < 0.0001). The disparity in survival between NHB and NHW women persisted after adjusting for age, diagnosis period, tumor stage, tumor histology/grade, and adjuvant treatment (HR = 1.64, 95% CI = 1.19 to 2.27). Multivariable analyses stratified by tumor features or treatment showed that the racial disparity was confined to women with low-risk features (stage I/II disease or low-grade EC) or no adjuvant treatment. CONCLUSION: There were racial differences in overall survival between NHB and NHW women with EC in the MHS equal access healthcare system, suggesting that factors other than access to care may be related to this racial disparity.
OBJECTIVE: The mortality rate for Black women with endometrial cancer (EC) is double that of White women, although the incidence rate is lower among Black women. Unequal access to care may contribute to this racial disparity. This study aimed to assess whether survival varied between non-Hispanic Black (NHB) and non-Hispanic White (NHW) women with EC in the Military Health System (MHS) which provides equal access care to its beneficiaries despite racial/ethnic background. METHODS: The study was conducted using data from the U.S. Department of Defense's (DoD) Automated Central Tumor Registry (ACTUR). Study subjects included NHB and NHW women with histologically confirmed and surgically managed EC diagnosed between 1988 and 2013. The study outcome was all-cause death. Overall survival between NHB and NHW women was compared using multivariable Cox modeling. RESULTS: The study included 144 NHB and 1439 NHW women with EC. Kaplan-Meier curves showed NHB women had worse survival than NHW women (log-rank P < 0.0001). The disparity in survival between NHB and NHW women persisted after adjusting for age, diagnosis period, tumor stage, tumor histology/grade, and adjuvant treatment (HR = 1.64, 95% CI = 1.19 to 2.27). Multivariable analyses stratified by tumor features or treatment showed that the racial disparity was confined to women with low-risk features (stage I/II disease or low-grade EC) or no adjuvant treatment. CONCLUSION: There were racial differences in overall survival between NHB and NHW women with EC in the MHS equal access healthcare system, suggesting that factors other than access to care may be related to this racial disparity.
Authors: Kate E Oliver; Lindsey R Enewold; Kangmin Zhu; Thomas P Conrads; G Scott Rose; G Larry Maxwell; John H Farley Journal: Gynecol Oncol Date: 2011-07-07 Impact factor: 5.482
Authors: Kristy K Ward; Nina R Shah; Cheryl C Saenz; Michael T McHale; Edwin A Alvarez; Steven C Plaxe Journal: Gynecol Oncol Date: 2012-04-13 Impact factor: 5.482
Authors: Edward R Kost; Kevin L Hall; Jeffrey F Hines; John H Farley; Lawrence R Nycum; G Scott Rose; Jay W Carlson; Joseph R Fischer; Brian S Kendall Journal: Gynecol Oncol Date: 2003-05 Impact factor: 5.482
Authors: John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; John I Risinger; J Tate Thigpen; Gini F Fleming; Holly H Gallion; G Larry Maxwell Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Mohamed A Elshaikh; Adnan R Munkarah; Jared R Robbins; Benjamin S Laser; Neil Bhatt; Chad Cogan; Farzan Siddiqui Journal: Gynecol Oncol Date: 2012-10-23 Impact factor: 5.482
Authors: Nestor F Esnaola; Bruce L Hall; Patrick W Hosokawa; John Z Ayanian; William G Henderson; Shukri F Khuri; Michael J Zinner; Selwyn O Rogers Journal: Ann Surg Date: 2008-10 Impact factor: 12.969
Authors: Yechiam Ostchega; Charles F Dillon; Jeffery P Hughes; Margaret Carroll; Sarah Yoon Journal: J Am Geriatr Soc Date: 2007-07 Impact factor: 5.562
Authors: Pamela Guggina; Julie Flahive; Frederick H Hooven; Nelson B Watts; Ethel S Siris; Stuart Silverman; Christian Roux; Johannes Pfeilschifter; Susan L Greenspan; Adolfo Díez-Pérez; Cyrus Cooper; Juliet E Compston; Roland Chapurlat; Steven Boonen; Jonathan D Adachi; Frederick A Anderson; Stephen Gehlbach Journal: Bone Date: 2012-09-03 Impact factor: 4.398